Articles tagged with Inflammatory Response
The researcher is investigating the inflammatory responses produced by exposure to chemical agents, comparing different chemical exposures at both whole-body and tissue levels. The study aims to develop a common treatment for chemical exposures and diagnose the responsible chemicals.
Researchers identified genes and cell types involved in rare inflammatory disease MIS-C in children following COVID-19 infection. The study found that specific immune cells are downregulated and associated with a sustained inflammatory response.
Researchers used a hamster model to study COVID-19 lung damage, discovering that the immune system's response plays a crucial role in disease progression. They found that certain cells involved in lung immunity ingest the virus, triggering an inflammatory response that can be brought under control by T cells.
Scientists discovered beige fat cells mediate subcutaneous fat's brain protection and provide anti-inflammatory effects. Beige fat transplantation restored cognitive function in obese mice with dementia-like behavior.
Researchers identified predictive molecular biomarkers for non-response to anti-TNF and anti-integrin therapies in UC. Biomarkers in innate and adaptive immune systems, as well as proteolytic degradation, were found to be predictive of therapy non-response.
A recent study by Queen Mary University of London provides new insight into the mechanisms behind uncontrolled inflammation in COVID-19 patients. The research found that treatments increasing specialised pro-resolving mediators (SPM) production, such as dexamethasone, may play a key role in limiting disease severity.
A recent study in Cell Stem Cell describes how cells remember past inflammation and use this memory to respond more efficiently to new threats. The phenomenon, known as trained immunity, allows cells to draw on general memories of inflammation to respond broadly.
A study found that antibodies produced to fight Covid-19 can trigger platelet activity, leading to fatal blood clots. Researchers developed a lab-based test to replicate this process, and suggest that existing medications may be able to inhibit platelet response.
Researchers identified three oral inflammation phenotypes: high, low, and slow responses. The 'slow' response was found in subjects with low clinical responses and demonstrated a delayed strong inflammatory response. A novel protective mechanism, utilizing neutrophils, was also discovered to save tissue and bone during inflammation.
Combining interscalene brachial plexus block with general anesthesia attenuates stress and inflammatory response in arthroscopic shoulder surgery. ISB/GA results in lower epinephrine, norepinephrine, and glucose levels, as well as reduced TNF-α and IL-6 levels.
Researchers identified an internal communication network in mammals that regulates tissue repair and inflammation. Endogenous retroviruses control this dialogue, affecting the host immune system and antimicrobial defenses.
A study published in Immunity found that COVID-19 causes severe inflammation in the brain, involving microglial cells and T-cell interactions. The research reveals a unique inflammatory pattern compared to other brain diseases, suggesting a misdirected immune response contributing to symptoms.
Researchers developed a cell-penetrating peptide to prevent septic shock in animal models. The treatment shows promise in protecting patients with metabolic syndrome and those at risk of severe COVID-19 complications.
A Z-RNA nanoswitch that switches from a right-handed A-RNA state to a left-handed Z-RNA state regulates immune responses against self RNAs. The switch is encoded by 'junk DNA' and protects normal cells from inflammatory diseases, while malfunctioning causes diseases like Aicardi-Goutieres disease.
A preclinical study by USF Health found that blocking lipoxygenase with a synthetic inhibitor alters the innate inflammatory response, delaying heart tissue repair after cardiac injury. The study suggests that preserving lipoxygenase is crucial for maintaining immune-mediated acute inflammation and preventing heart failure.
A comprehensive review suggests COVID-19 infects both upper and lower respiratory tracts, causing a uniquely aggressive immune response that leads to severe health issues months after infection. This dysregulation of the immune response contributes to long-COVID and severe lung damage in some individuals.
Researchers at McGill University developed a novel approach using silicone and sugar to create the softest brain implant yet. The new implants have shown reduced inflammation and higher neuronal density compared to traditional hard implants.
Researchers found that a shortage of DNA building blocks triggers an inflammatory response in cells when mitochondria release their genetic material. This link could lead to new treatments for various diseases associated with the mitochondrial genome and ageing process.
Researchers identified GAPLINC, a long noncoding RNA that regulates inflammatory gene expression and protects mice from septic shock. The study found that reducing GAPLINC levels enhanced inflammatory responses, but unexpectedly, this effect also protected mice from endotoxic shock.
A Phase II clinical trial is being conducted to evaluate the safety and efficacy of MultiStem cellular therapy for treating injured patients with severe hemorrhage. The study aims to mitigate complications resulting from traumatic injuries, including secondary infections and organ failure conditions.
A study by Cincinnati Children's Hospital Medical Center found that targeting the BCAP protein could help control overactive immune responses and promote tissue repair in inflammatory diseases. The researchers suggest that modulating BCAP activity could be used to dampen inflammation and accelerate response against tumors.
Bats use unique strategies to tolerate zoonotic viruses, preventing overactive immune responses that protect them from diseases. The team identified mechanisms that balance key proteins involved in immunity and inflammation, enabling bats to harbour pathogens without getting sick.
This study examines the effects of talc on mesothelial and neoplastic cells, revealing high levels of IL-6 and TNFRI. The results suggest that normal mesothelium is the main stimulus for the inflammatory process, with talc inducing higher rates of apoptosis in neoplastic cells.
A new study found that rheumatoid arthritis is associated with a 23% increased risk of developing type 2 diabetes. The research suggests that systemic inflammation may contribute to the development of diabetes in individuals with RA, highlighting the need for more intensive screening and management of diabetes risk factors.
Researchers at Columbia University Irving Medical Center discovered a distinct antibody profile in patients with non-celiac gluten sensitivity, which differs from those with celiac disease. This finding could lead to better detection methods and potential new therapies for celiac disease treatment.
Researchers at Harvard Medical School used acupuncture to regulate inflammatory responses and improve survival in mice with cytokine storm. The study found that site, intensity, and timing of treatment influenced the response.
Researchers identified HDAC3 as orchestrator of immune system's inflammation response to infection, with both triggering and reducing inflammation. The study highlights the need to target non-enzymatic functions of HDAC3 instead of its enzyme activity to mitigate lethal outcomes.
A study found that type 1 interferon deficiency is a biomarker for patients at risk of severe COVID-19. Low levels of type 1 interferon in plasma precede clinical worsening and are characteristic of each stage of the disease, suggesting it could identify a high-risk population.
A study of 50 COVID-19 patients revealed a distinctive 'hallmark' of severe disease, characterized by interferon deficiency and exacerbated inflammation. This signature may inform therapeutic approaches combining interferon supplementation with anti-inflammatory treatments.
A new single-cell RNA sequencing analysis of over 59,000 cells from COVID-19 patients and influenza patients reveals distinct immune responses to both diseases. The study suggests targeting the IFN-I signaling pathway as a potential treatment strategy for severe COVID-19.
Researchers found that bats' ability to control inflammation may hold clues to developing new treatments for diseases in humans. By understanding the mechanisms underlying bats' unique abilities, scientists may be able to develop therapies to fight diseases like COVID-19.
New research from Saarland University suggests that low levels of the stress hormone cortisol and protein GILZ can trigger chronic inflammatory responses in the body. This leads to macrophage ageing, which impairs immune cells' ability to control inflammation, resulting in increased pro-inflammatory signalling molecules.
Researchers found an immune system cell called interleukin-6 (IL-6) triggers inflammation in times of stress, worsening health problems such as diabetes and autoimmune disease. Blocking IL-6 production protects stressed mice from inflammation and alleviates symptoms of depression.
The study found that female neutrophils have enhanced proinflammatory genes and responses to inflammatory stimuli compared to male neutrophils. Sex hormones may drive these differences, with males exhibiting increased mitochondrial metabolism in their neutrophils.
A recent study published in Nature Medicine found that healthy adults exhibit a wide range of metabolic responses to food, with inflammation triggered by eating varying up to ten-fold. This suggests personalized diets can help reduce inflammation and improve health.
Research published in Nature Genetics found that the three-dimensional structure of the human genome is essential for a rapid and robust inflammatory response. The discovery sheds light on the fundamental relationship between genome folding and cell function, highlighting the importance of architectural proteins like CTCF.
Researchers find that repositioning the spleen during surgery can lead to physical changes and altered immune responses, suggesting a key role of mesothelial cells in modulating inflammation. The study suggests that breaking connections between these cells and the spleen may have consequences for immune function.
A new study finds that e-cigarettes cause a proinflammatory response in the oral microbiome, coating commensal bacteria with slime and disrupting healthy colonization. The glycerol/glycol vehicle in e-cigarettes appears to drive these changes, according to researchers who analyzed bacterial genes in plaque samples from e-cigarette users.
Researchers have discovered that increasing levels of lipid mediators derived from omega-3 fatty acids can turn off inflammation caused by SARS-CoV-2, a hallmark symptom of severe COVID-19 illness. This approach may be as important as antiviral therapies or vaccines in reducing associated organ damage and mortality.
Researchers at Monash University have discovered the mechanism behind one of two signalling arms involved in the cGAS-STING pathway. The findings reveal that a closely related TBK1 homologue, IKK-epsilon, plays a crucial role in cytokine production, leading to new understanding of autoimmune diseases and cancer treatment.
Researchers found that a commonly used drug, ursodiol, can reduce inflammation in mice infected with C. difficile and inhibit the life cycle of the bacteria. The study suggests that ursodiol may be a viable alternative to antibiotic treatments for C. diff infections.
Activated platelets attach to vessel walls and interact with mast cells, triggering a powerful inflammatory response that can lead to organ damage and death after heart surgery. Inhibiting platelet activation may prevent or minimize this response, according to a study published in Science Advances.
A study published in Immunity identifies an enzyme that blocks self-healing in blood vessels during inflammation, hindering regeneration. Removing this enzyme allows cells to fully regenerate, suggesting a potential therapeutic target for improving endogenous regeneration.
Research suggests that inflammation-related genes are associated with biobehavioral factors like body mass index and smoking, while interferon-related genes are linked to individual demographic factors such as sex and race/ethnicity. The study's findings could help explain social disparities in chronic diseases that emerge decades later.
Researchers have developed injectable hydrogels that can tune the body's inflammatory response, promoting or reducing inflammation as needed. The study found that positively charged hydrogels triggered stronger responses for wound-healing and cancer treatment, while negatively charged gels were better suited for drug delivery.
A recent study published in the Journal of Nutritional Biochemistry found that humans have highly individualized inflammatory responses to eating a high-fat meal. The researchers used a sensitive test to analyze gene expression in response to the meal, finding that responses by more than 13,000 genes differed between subjects.
Initial urinary tract infections can cause long-lasting changes to the bladder's immune response, making it more prone to future infections. The study found that targeting TNF-alpha or other inflammatory responses may help prevent or alleviate recurrent UTIs.
A study published in the Journal of Experimental Medicine found that phosphorylation of Regnase-1 allows IL-17 to trigger inflammation. Blocking this phosphorylation process could lead to therapeutic agents for treating autoimmune diseases related to IL-17, such as rheumatoid arthritis and multiple sclerosis.
Researchers identified a potential new therapeutic target for sepsis by uncovering a pathway involving Lipopolysaccharide (LPS) that could suppress the inflammatory response. This discovery offers a promising approach to treating sepsis, which can lead to organ failure and death if not recognized early.
A team of researchers from Trinity College Dublin has discovered that SARM plays an important role in the immune response and regulates inflammation. The study suggests that targeting SARM could provide a new option for treating diseases such as diabetes, cancer, and Alzheimer
A research team identified molecular and genetic mechanisms allowing bats to host multiple viral pathogens without suffering diseases. Bats have a unique ability to limit inflammation, which may be key to their long lifespans and virus reservoir status.
A study published in Scientific Reports identifies changes to neutrophils that increase vulnerability of obese and diabetic individuals to infection. Alterations to neutrophils, a type of white blood cell, lead to impaired activation of toll-like receptors (TLRs), weakening the immune system's ability to combat pathogens.
Scientists at the University of British Columbia have discovered a new protein 'switch' that can stop the progression of sepsis, a life-threatening disease. This discovery could lead to new treatments for chronic and acute inflammatory diseases.
Researchers found that NSAID carprofen triggered low-grade inflammation in the heart and kidneys, amplifying cardiorenal syndrome. Biomarkers of kidney injury increased, indicating compromised glomerular structure integrity.
A new study found that an HIV drug reduces age-related inflammation and signs of aging in mice, holding promise for treating Alzheimer's and other diseases. The drug works by halting retrotransposon activity in old cells, which are linked to age-associated disorders.
Researchers have identified a novel form of inflammatory regulation that increases response to painful stimuli. A protein fragment, ARD, plays a key role in this process, increasing PI3K activity and sensitizing pain receptors.
A new microneedle patch vaccine containing the inactivated RSV virus has been shown to be effective in enhancing protection against the disease and reducing inflammation. The vaccine, combined with an immune-stimulating compound, was found to induce a stronger immune response than traditional intramuscular vaccination.
Researchers studying fetal exposure to inflammation aim to understand its impact on infant immune responses and potential prevention methods. High levels of Th17 cells in pregnancy-inflammation mothers and preterm babies have been linked to tissue damage, but their role in infection protection is unclear.
Researchers from the Luxembourg Institute of Health uncover distinct microglial signatures in response to acute inflammation, highlighting potential benefits for resolving inflammation. Their single-cell transcriptomic study provides new resources for understanding brain disorders and developing novel therapeutic strategies.
A new study finds that long noncoding RNA lincRNA-Cox2 regulates the activity of genes involved in inflammation and immune system responses. It boosts production of the Cox2 enzyme and influences expression of other genes, shedding light on previously dismissed 'junk DNA' functions.